side effects semaglutide vs tirzepatide vs. for Weight Loss: Results, & How to Choose Semaglutide vs. Tirzepatide: Understanding Which

For eligible adults with clinically significant obesity, MHRA-approved options include semaglutide (Wegovy, assessed in NICE TA875) and tirzepatide (Mounjaro, assessed in NICE TA1026), both available through NHS pathways with appropriate clinical oversight

Tool: Mediterranean Diet, DASH Diet (00:33:25) Food Choices & Sleep Quality, Food Timing (00:39:33) Sponsor: AG1 (00:40:52) Personal Circadian Clock, Shift Work

Some users report better tolerance when they can sleep through the initial 8-12 hours post-injection

This means your core treatment options are identical regardless of which platform you choose

"Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)." N Engl J Med